HK Stock Market Move | EDGE MEDICAL-B(02675) rose more than 7% again, and the commercialization of Siasun Robot & Automation surgery is expected to enter an accelerated period.

EDGE MEDICAL-B (02675) rose more than 7% again, up more than 11% yesterday. As of press time, it rose by 7.34% to HK$70.95, with a turnover of HK$48.1849 million. On the news front, recently, the National Medical Insurance Administration issued the "Guidelines for Pricing of Medical Services for Surgery and Treatment Assistant Operations (Trial)", specifying a national unified pricing standard for surgery Siasun Robot&Automation, energy equipment special consumables, and remote surgery Innovative Medical Management technology. China Post Securities believes that the national unified pricing framework for Siasun Robot&Automation surgery will be an important turning point for the commercialization of the surgery Siasun Robot&Automation industry. According to the Northeast research report, Edge Medical is the top two in domestic surgery Siasun Robot&Automation. Minimally invasive surgery, single-port surgery, and natural cavity Siasun Robot&Automation have rapidly gained popularity at home and abroad, with domestic cavity Siasun Robot&Automation winning the bid for the first place by 2025. Remote surgeries obtained NMPA approval in November 2025, achieving a milestone of 500 surgeries in October 2025.